title: Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, UCLA Lung Cancer Research Program, Johnsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA 90095-1690, USA. sdubinett@mednet.ucla.edu
authors.forename: Steven M
authors.initials: SM
authors.lastname: Dubinett
authors.forename: Jenny T
authors.initials: JT
authors.lastname: Mao
authors.forename: Saswati
authors.initials: S
authors.lastname: Hazra
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000201:enzymology / Q000235:genetics / Q000517:prevention & control*; D018890:Chemoprevention / Q000379:methods*; D051546:Cyclooxygenase 2 / Q000502:physiology; D016503:Drug Delivery Systems; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D016147:Genes, Tumor Suppressor / Q000502:physiology; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases / Q000235:genetics* / Q000502:physiology; D008175:Lung Neoplasms / Q000201:enzymology / Q000517:prevention & control*; D015398:Signal Transduction / Q000187:drug effects / Q000235:genetics; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D045162:Thiazolidinediones; D006911:Hydroxyprostaglandin Dehydrogenases; C035859:15-hydroxyprostaglandin dehydrogenase; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human